|                   | 
    
    
    | Goal  
      #1 | To  
      more accurately monitor the HIV epidemic and provide data to assess and  
      direct prevention programs by strengthening existing systems and developing  
      new surveillance systems. |    
    | Objectives |  
        Implement  
          projects that evaluate and expand the uses of HIV infection and AIDS  
          case surveillance and sero-surveillance data so that these data systems  
          can more effectively guide public health policy and provide relevant  
          information necessary to direct and evaluate prevention activities.  
           Improve  
          understanding of the natural history of HIV infection as well as the  
          risk factors and protective factors for sexual, drug-related, perinatal,  
          and healthcare worker related HIV transmission in order to develop more  
          effective prevention strategies for all affected populations.  |    
    | Action  
        Steps |  
        Evaluate  
          HIV infection reporting systems (named, anonymous, unique identifier)  
          used nationally for their ability to monitor the epidemic, provide linkages  
          to medical and social services, and to assess their impact on a person's  
          decision to be tested. Characterize  
          high-risk behaviors of persons with evidence of recent HIV infection  
          such as persons with documented HIV seroconversion, high CD4+ counts,  
          or diagnosis of HIV infection in adolescents. Assess  
          the impact of public health guidelines and recommendations and prevention  
          efforts. Characterize persons co-infected with TB and HIV. Evaluate  
          ways to improve the completeness and quality of risk ascertainment on  
          persons reported with HIV and AIDS. Identify and characterize previously  
          unreported AIDS cases among deaths investigated by local medical examiners  
          to assess the impact of under-diagnosis of AIDS cases on AIDS surveillance  
          among disadvantaged populations that often do not receive adequate health  
          care. Test  
          the efficiency of new techniques for reporting HIV and AIDS surveillance  
          data from health care providers and laboratories to health departments. Collect  
          additional data on persons reported through HIV/AIDS surveillance which  
          may be important for the planning and evaluation of prevention and care  
          programs, such as social/economic status, levels of disabilities, drug  
          use history, sex behavior history, utilization of HIV testing and medical  
          care services, and reproductive history in women. Assess  
          the interrelationship of behaviors, HIV markers and surrogates, and  
          their potential role in surveillance systems. Assess  
          the interaction of socioeconomic, behavioral, and biologic factors in  
          HIV transmission. Determine  
          the role of female-specific biological factors that are linked to acquisition  
          and transmission of HIV infection and that influence the course of HIV  
          disease. Determine  
          factors contributing to the efficiency of sexual transmission of HIV. Assess  
          the risk of transmission of HIV and TB from HIV-infected health-care  
          worker to patient and vice versa. Develop systems to monitor the emergence  
          of multidrug-resistant TB in the HIV infected. Continue  
          to develop improved methods for projecting or modeling the HIV epidemic. Develop  
          methods to differentiate HIV-specific antibodies generated in participants  
          in HIV vaccine trials from those generated in response to HIV infection. Develop  
          methods to identify potential cases of HCW-to-patient transmission. Expand  
          HIV reporting systems to collect information about primary and secondary  
          HIV prevention services needed and received by HIV-positive clients  
          (in collaboration with HRSA). Work  
          with providers and users of lab services to develop and implement systems  
          which provide assurance that the capacity and quality requirements for  
          HIV testing are met. Work  
          with international partners to study TB, implement vaccine trials, enhance  
          clinical management, assess prevention efficacy, and improve program  
          management of HIV/AIDS. Develop  
          methods to evaluate the use of HIV infection and AIDS surveillance systems  
          to assess early intervention strategies.  |    
    | Descriptions | Many of  
        the activities in the above-cited action steps are carried out through  
        cooperative agreements with state and local health departments. In addition,  
        specialized projects and studies also serve to focus attention on these  
        activities, these include:    
        Evaluation  
          of HIV Infection Reporting Systems Project Recent  
          HIV Infection ProjectsSurveillance  
          to Evaluate Prevention ProjectsAdult  
          Spectrum of Disease ProjectTB ProjectMode  
          of Transmission Validation ProjectMedical  
          Examiner StudyEnhancement  
          of AIDS Surveillance Efficiency Projec |    
    | Resources | FY95 | FY96 | FY96 |    
    | $  
        141 million | $  
        140 million | $  
        140 million |    
    | PopulationsServed
 | All  
      major racial, ethnic, and risk groups. |    
    | ConstituencyInvolvement
 | There  
      is regular consultation with national, State, and local public health officials  
      and many other relevant organizations such as HIV-related community-based  
      organizations. |             
 President and First Lady | Vice President and Mrs. GoreRecord of Progress | The Briefing Room
 Gateway to Government | Contacting the White House
 White House for Kids | White House History
 White House Tours | Help | Text Only
 Privacy Statement |  |